Answers are grounded in this paper and cite their sources.
Bone marrow acid phosphatase was determined by radioimmunoassay and enzymatic analysis in 95 patients with benign prostatic hypertrophy, 50 patients with disseminated prostatic carcinoma and 36 patients with non-prostatic malignancy. The results indicate superior specificity of the radioimmunoassay. A brief review of the topic and the clinical implications are discussed.
No takes yet. Share an insight, caveat, or question.
Belville et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: